pone.0200053.g003.tif (966.26 kB)

Site displacement studies using site-specific markers; Phenylbutazone (PHEB) was used as marker for HSA domain IIA (Sudlow site I).

Download (966.26 kB)
figure
posted on 07.11.2018 by Shreya Dubey, Monika Kallubai, Arijit Sarkar, Rajagopal Subramanyam

Fluorescence spectroscopic studies performed using HSA and Phenylbutazone at equal concentrations (1μM) and drugs with increasing concentrations (1μM ~ 9μM) (A) HSA-PHEB-withanolide A (B) HSA-PHEB-withanolide B (C) HSA-PHEB-withanoside IV and (D) HSA-PHEB-withanoside V.

History

Licence

Exports